Dustin D. Armstrong
Founder at Valerion Therapeutics LLC
Network origin in Dustin D. Armstrong first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Valerion Therapeutics LLC
 Valerion Therapeutics LLC Medical SpecialtiesHealth Technology Valerion Therapeutics LLC develops targeted therapies for orphan genetic diseases. The firm utilizes a proprietary antibody-mediated delivery platform to target therapies to specific tissues via a studied transport pathway. It therapies are based on an intracellular delivery technology platform that takes advantage of tissue targeting via an antibody and intracellular delivery dependent on membrane expression of a nucleoside transporter. The company was founded by Timothy S. Harris and Dustin D. Armstrong in 2007 and is headquartered in Concord, MA.
5
| Holding Company | Medical Specialties | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Dustin D. Armstrong via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Biotechnica International, Inc.
 Biotechnica International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Groupe Limagrain Holding SA, Biotechnica International, Inc. is a company that specializes in agricultural research. The company is based in Shawnee Mission, KS. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| IMMUNOGEN, INC. | Biotechnology | General Counsel | |
| REPLIGEN CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Virus Research Institute, Inc.
 Virus Research Institute, Inc. BiotechnologyHealth Technology Part of Celldex Therapeutics, Inc., Virus Research Institute, Inc. develops systems for the delivery of vaccines. The company is based in Cambridge, MA. | Biotechnology | General Counsel | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree | |
GPC Biotech, Inc.
 GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Drugstore Chains | Corporate Officer/Principal | |
Ethicon Endo-Surgery, Inc.
 Ethicon Endo-Surgery, Inc. Medical SpecialtiesHealth Technology Ethicon Endo-Surgery, Inc. manufactures surgical devices and equipments. Its products include the ENDOPATH XCEL access system, CONTOUR curved cutter stapler, HARMONIC ultrasonic cutting and coagulation surgical devices and the MAMMOTOME breast biopsy system. The company was founded in 1992 and is headquartered in Cincinnati, OH. | Medical Specialties | Corporate Officer/Principal | |
| Boston College | College/University | Graduate Degree | |
| Yale University | College/University | Corporate Officer/Principal | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree | |
| Baylor College of Medicine | College/University | Doctorate Degree | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Enobia Pharma, Inc.
 Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
| Alopexx Pharmaceuticals LLC | Chief Executive Officer | ||
| University of Pittsburgh School of Medicine | College/University | Corporate Officer/Principal | |
Alopexx Enterprises LLC
 Alopexx Enterprises LLC BiotechnologyHealth Technology Alopexx Enterprises LLC engages in investing and managing health care companies. It develops medical therapies and devices for infectious diseases, oncology, central nervous system, and orphan diseases. The firm commercializes an alternative for the treatment and prevention of staphylococcal and other bacterial infections and animal vaccines. The company was founded by Daniel R. Vlock, Deborah Ramsdell and Christine de los Reyes in 2011 and is headquartered in Concord, MA. | Biotechnology | General Counsel Chief Executive Officer | |
Orphan Technologies Ltd.
 Orphan Technologies Ltd. Pharmaceuticals: MajorHealth Technology Orphan Technologies Ltd. engages in the manufacturing of biopharmaceutical drugs. It develops novel therapies for patients suffering from rare disorder and classical homocystinuria. The company is headquartered in Rapperswil, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
| TRANSCODE THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Phoenicis Therapeutics, Inc.
 Phoenicis Therapeutics, Inc. BiotechnologyHealth Technology Phoenicis Therapeutics, Inc. is a private company that is focused on developing therapies for rare dermatological disorders. The company is based in Hingham, MA. The company's goal is to improve the lives of those who suffer from these conditions. The CEO of the company is Deborah Ramsdell. | Biotechnology | Director/Board Member Chief Executive Officer | |
| Alopexx Vaccines LLC | Chief Executive Officer | ||
| ALOPEXX, INC. | Biotechnology | Chief Executive Officer |
Statistics
International
| United States | 28 |
| Canada | 2 |
| Switzerland | 2 |
Sectoral
| Health Technology | 19 |
| Consumer Services | 8 |
| Commercial Services | 2 |
| Retail Trade | 2 |
Operational
| Corporate Officer/Principal | 9 |
| Chief Tech/Sci/R&D Officer | 7 |
| Chief Executive Officer | 7 |
| Director/Board Member | 6 |
| President | 5 |
Most connected contacts
| Insiders | |
|---|---|
| Daniel R. Vlock | 17 |
| Deborah Ramsdell | 11 |
| Hal Landy | 7 |
| Timothy S. Harris | 1 |
| Randy Wingate | 1 |
- Stock Market
- Insiders
- Dustin D. Armstrong
- Company connections
